|
Market Closed -
Nasdaq
06:00:00 12/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 54.54 USD | +2.98% |
|
+5.86% | +37.87% |
| 04/09 | Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing | MT |
| 02/09 | Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,774 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 41.05% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,622 | 2,548 | 2,453 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 40.01% | -2.83% | -3.71% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 517x | 130x | 78.5x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 4.79x | 4.27x | 3.74x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 0x | 1.2x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 4.58x | 4.08x | 3.63x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.33x | 3.75x | 3.21x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 30x | 25x | 19.8x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 229x | 102x | 57.7x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 49.4x | 63.6x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 2.02% | 1.57% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.4186 | 0.6946 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.2 | 679.6 | 764.6 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 101.7 | 124 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.51 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.112 | 20.78 | 35.22 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -152.1 | -226.3 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 54.54 | 54.54 | 54.54 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/2/22 | 21/2/23 | 15/2/24 | 12/2/25 | 17/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 516.58x | 4.33x | 29.97x | -.--% | 2.77B | |
| 28.88x | 3.99x | 15.42x | 2.52% | 176B | |
| 19.24x | 3.52x | 12.58x | 3.12% | 116B | |
| 17.61x | 0.2x | 12.86x | 0.74% | 61.36B | |
| 27.83x | 6.83x | 17.6x | 1.44% | 49.42B | |
| 34.27x | 3.34x | 11.43x | 2.21% | 48.44B | |
| 33.28x | 5.85x | 18.35x | -.--% | 31.33B | |
| 42x | 1.24x | 11.46x | 0.22% | 28.56B | |
| 40.38x | 7.07x | 25.37x | 0.26% | 24.37B | |
| 16.74x | 2.67x | 9.46x | 1.65% | 21.57B | |
| Average | 77.68x | 3.90x | 16.45x | 1.22% | 56.06B | |
| Weighted average by Cap. | 29.38x | 3.72x | 14.64x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
